F32 F33
Conditions
Interventions
Group 1: n = 12 adult patients with a diagnosis of depressive disorder who receive real ILF neurofeedback
Group 2: n = 12 adult patients diagnosed with depressive disorder who receive sham ILF neurofe
Sponsors
Universitätsklinikum Bonn, Klinik für Psychiatrie und Psychotherapie
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Current diagnosis of unipolar depression according to DSM-V or ICD-10, minimum sum score of 9 on the GRID-HAMD-17 rating, sufficient understanding of the German language
Exclusion criteria
Exclusion criteria: Signs of increased risk of suicidality (GRID-HAMD item 3 score > 2 or indications in MINI-DIPS screening), psychotic symptoms, bipolar disorder / manic symptoms, disorders from the schizophrenia spectrum, substance dependence, epilepsy or other underlying neurological disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression symptom reduction (self-report and other-report) from T0 to T1, T2, and T3. | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in quality of life and comorbid anxiety and stress symptoms from T0 to T1, T2, and T3. Further improvement in attention, and changes in EEG (ERPs) and fNIRS (oxy- and deoxy-Hb) from T0 to T2. | — |
Countries
Germany
Contacts
Public ContactAnnika Wiebe
Universitätsklinikum Bonn, Klinik für Psychiatrie und Psychotherapie
Outcome results
None listed